Clinical trial
Cryoablation of Small Breast Tumors in Early Stage Breast Cancer
NCT01992250 · Sanarus Technologies, Inc., Industry · Unknown status
Key facts
| NCT number | NCT01992250 |
|---|---|
| Title | Cryoablation of Small Breast Tumors in Early Stage Breast Cancer |
| Official title | Freezing Alone Instead of Resection Of Small Breast Tumors: A Study of Cryoablation in the Management of Early Stage Breast Cancer |
| Acronym | FROST |
| Lead sponsor | Sanarus Technologies, Inc., Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Device |
| Interventions | Visica 2 Treatment System |
| Enrollment | 200 |
| Start date | Nov 1, 2013 |
| Primary completion | Dec 1, 2021 |
| Completion | Jun 1, 2023 |
| First posted | Nov 25, 2013 |
| Last update posted | Apr 20, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: